Overview
Matthew Bird practices in Leuven, Belgium. Mr. Bird is rated as an Advanced expert by MediFind in the treatment of PGM1-CDG. His top areas of expertise are PGM1-CDG, Chanarin-Dorfman Syndrome, and Nonbullous Congenital Ichthyosiform Erythroderma.
His clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of PGM1-CDG.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- PGM1-CDGMr. Bird isAdvanced. Learn about PGM1-CDG.
- Experienced
- Chanarin-Dorfman SyndromeMr. Bird isExperienced. Learn about Chanarin-Dorfman Syndrome.
- Nonbullous Congenital Ichthyosiform Erythroderma